Sarah James
Stock Analyst at Cantor Fitzgerald
(1.95)
# 3,161
Out of 5,115 analysts
301
Total ratings
34.51%
Success rate
-7.29%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Maintains: Overweight | $525 → $588 | $488.27 | +20.43% | 22 | Jan 28, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $13.44 | +26.49% | 18 | Dec 3, 2025 | |
| CNC Centene | Maintains: Neutral | $38 → $41 | $43.32 | -5.36% | 16 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $74.52 | +27.48% | 16 | Oct 30, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $227 → $250 | $201.26 | +24.22% | 27 | Oct 29, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $189.28 | +29.44% | 23 | Oct 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $210 → $180 | $179.59 | +0.23% | 14 | Oct 24, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $14.86 | +142.26% | 13 | Oct 7, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | $4 | $2.15 | +86.05% | 8 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $286.93 | +53.35% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $274.11 | +33.16% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $23.87 | +17.30% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $195.20 | +48.57% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $345.74 | +40.28% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $19.35 | +49.87% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $3.24 | +362.96% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $0.77 | +552.23% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $5.45 | +83.49% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $109.34 | +21.64% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $25.13 | +67.13% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $5.55 | -9.91% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $8.40 | -40.48% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $22.53 | -6.79% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $70.10 | -44.37% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $75.48 | +155.70% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.21 | - | 2 | Mar 1, 2017 |
HCA Healthcare
Jan 28, 2026
Maintains: Overweight
Price Target: $525 → $588
Current: $488.27
Upside: +20.43%
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $13.44
Upside: +26.49%
Centene
Oct 30, 2025
Maintains: Neutral
Price Target: $38 → $41
Current: $43.32
Upside: -5.36%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $74.52
Upside: +27.48%
Universal Health Services
Oct 29, 2025
Maintains: Neutral
Price Target: $227 → $250
Current: $201.26
Upside: +24.22%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $189.28
Upside: +29.44%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $210 → $180
Current: $179.59
Upside: +0.23%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $14.86
Upside: +142.26%
Health Catalyst
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $2.15
Upside: +86.05%
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $286.93
Upside: +53.35%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $274.11
Upside: +33.16%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $23.87
Upside: +17.30%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $195.20
Upside: +48.57%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $345.74
Upside: +40.28%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $19.35
Upside: +49.87%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $3.24
Upside: +362.96%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $0.77
Upside: +552.23%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $5.45
Upside: +83.49%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $109.34
Upside: +21.64%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $25.13
Upside: +67.13%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $5.55
Upside: -9.91%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $8.40
Upside: -40.48%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $22.53
Upside: -6.79%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $70.10
Upside: -44.37%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $75.48
Upside: +155.70%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.21
Upside: -